A Retrospective Controlled Cohort Study of the Impact of Glucocorticoid Treatment in SARS-CoV-2 Infection Mortality
Antiviral Agents
[키워드] acute respiratory syndrome
adjusted
confidence interval
Control
Controlled
coronavirus
coronavirus disease
COVID-19
determine
glucocorticoid
hazard ratio
hospital
hospitalized patient
Impact
in-hospital mortality
inclusion criteria
initial
initial treatment
interquartile range
log rank test
median time
Methylprednisolone
Mortality
not different
Odds ratio
Patient
patients treated
patients with SARS-CoV-2
performed
Pneumonia
pulse
Rate
reduced
regimen
retrospective cohort study
risk reduction
SARS-CoV-2
single-center
Spain
steroid
steroid treatment
Steroids
study period
Support
survival
survival time
symptom onset
treated
Treatment
university hospital
use of steroid
with COVID-19
[DOI] 10.1128/AAC.01168-20 PMC 바로가기 [Article Type] Antiviral Agents
[DOI] 10.1128/AAC.01168-20 PMC 바로가기 [Article Type] Antiviral Agents